GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » 3-Year EPS without NRI Growth Rate

Orion Pharma (DHA:ORIONPHARM) 3-Year EPS without NRI Growth Rate : -1.20% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma 3-Year EPS without NRI Growth Rate?

Orion Pharma's EPS without NRI for the three months ended in Mar. 2024 was BDT0.42.

During the past 12 months, Orion Pharma's average EPS without NRI Growth Rate was -34.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was -1.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Orion Pharma was 5.40% per year. The lowest was -5.50% per year. And the median was -2.70% per year.


Competitive Comparison of Orion Pharma's 3-Year EPS without NRI Growth Rate

For the Utilities - Independent Power Producers subindustry, Orion Pharma's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's 3-Year EPS without NRI Growth Rate Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Orion Pharma's 3-Year EPS without NRI Growth Rate falls into.



Orion Pharma 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Orion Pharma  (DHA:ORIONPHARM) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Orion Pharma 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Orion Pharma's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma (DHA:ORIONPHARM) Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines